Search, Find and Buy Antibodies, ELISA Kits and Proteins.
Loading Loading
Add to Basket
Order hotline:
phone +1 404 474 4654
fax +1 888 205 9894 (TF)
Details for Product No. ABIN968103

tau (AA 23-179) antibody

Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

»Alternatives AA 23-179
»Alternatives Human
»Alternatives Mouse
Clonality (Clone) Monoclonal ()
»Alternatives Un-conjugated
»Alternatives Western Blotting (WB), Immunofluorescence (IF)
Pubmed 5 references available
Catalog no. ABIN968103
Quantity 50 µg
Contact our Customer Service for availability and price in your country.
Shipping to
Immunogen Human Tau
Clone Ghr5
Isotype IgG2b
Cross-Reactivity Rat (Rattus)
Characteristics 1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Please refer to us for technical protocols.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
4. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
Purification Purified from tissue culture supernatant or ascites by affinity chromatography.
Purity Purified
Background In addition to tubulin, microtubules have other components named Microtubule-associated proteins (MAPs), which include the high molecular MAPs (200-400 kDa) and the Tau proteins (55-70 kDa). These proteins co-purify with the microtubules during repeated cycles of microtubule assembly and disassembly. Both MAPs and Tau proteins extend from the side of the microtubules. They form cross-bridges in neurons and bind tubulin by their C-terminal region. The heterogeneity in the molecular weight of Tau proteins is due to post-translational modifications and different numbers of tandem repeats in their C-terminal domain. Tau isoforms are selectively expressed in unique subsets of neurons and regulated during development. The highly phosphorylated Tau proteins have also been detected in the neurofibrillary tangles of Alzheimer's patients. This antibody is routinely tested by western blot analysis.
Molecular Weight 50-68 kDa
Research Area Neurology, Cytoskeleton, Alzheimer's Disease

Related Products: ABIN968545, ABIN967389

Restrictions For Research Use only
Format Liquid
Concentration 250 µg/ml
Buffer Aqueous buffered solution containing BSA, glycerol.
Preservative Sodium azide
Storage -20 °C
Product cited in: Goedert, Spillantini, Potier et al.: "Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain." in: The EMBO journal, Vol. 8, Issue 2, pp. 393-9, 1989 (PubMed).

Kanai, Hirokawa: "Sorting mechanisms of tau and MAP2 in neurons: suppressed axonal transit of MAP2 and locally regulated microtubule binding." in: Neuron, Vol. 14, Issue 2, pp. 421-32, 1995 (PubMed).

Alonso, Grundke-Iqbal, Iqbal: "Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules." in: Nature medicine, Vol. 2, Issue 7, pp. 783-7, 1996 (PubMed).

Wilson, Binder: "Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease." in: The American journal of pathology, Vol. 150, Issue 6, pp. 2181-95, 1997 (PubMed).

Takeda, Hatai, Hamazaki et al.: "Apoptosis signal-regulating kinase 1 (ASK1) induces neuronal differentiation and survival of PC12 cells." in: The Journal of biological chemistry, Vol. 275, Issue 13, pp. 9805-13, 2000 (PubMed).

Alternatives for antigen "tau", type "Antibodies"
Hosts (295), (28), (5), (1)
Reactivities (317), (253), (244), (15), (3), (2), (2), (2), (1), (1), (1), (1)
Applications (287), (161), (70), (20), (13), (13), (13), (13), (12), (9), (9), (7), (1), (1), (1), (1)
Conjugates (2), (1), (1), (1)
Epitopes (25), (16), (14), (13), (12), (12), (12), (11), (10), (10), (10), (9), (9), (8), (5), (4), (4), (4), (4), (3), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1)